Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - GB
$ 1.39
-6.08 %
$ 2 M
Market Cap
0.0
P/E
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.[ Read More ]
The intrinsic value of one AKAN stock under the base case scenario is HIDDEN Compared to the current market price of 1.39 USD, Akanda Corp. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart AKAN
FINANCIALS
2.16 M
REVENUE
-10.1 M
OPERATING INCOME
-32.3 M
NET INCOME
-1.5 M
OPERATING CASH FLOW
24.9 K
INVESTING CASH FLOW
1.49 M
FINANCING CASH FLOW
477 K
REVENUE
-2.35 M
OPERATING INCOME
-2.22 M
NET INCOME
-2.59 M
OPERATING CASH FLOW
104 K
INVESTING CASH FLOW
8.64 M
FINANCING CASH FLOW
Balance Sheet Decomposition
Akanda Corp.
| Current Assets | 1.81 M |
| Cash & Short-Term Investments | 93.9 K |
| Receivables | 285 K |
| Other Current Assets | 1.43 M |
| Non-Current Assets | 7.03 M |
| Long-Term Investments | 593 K |
| PP&E | 2.64 M |
| Other Non-Current Assets | 3.8 M |
| Current Liabilities | 10.2 M |
| Accounts Payable | 6.01 M |
| Short-Term Debt | 1.5 M |
| Other Current Liabilities | 2.66 M |
| Non-Current Liabilities | 2.5 M |
| Long-Term Debt | 2.5 M |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
Akanda Corp.
| Revenue | 2.16 M |
| Cost Of Revenue | 2.05 M |
| Gross Profit | 111 K |
| Operating Expenses | 3.48 M |
| Operating Income | -10.1 M |
| Other Expenses | 22.2 M |
| Net Income | -32.3 M |
RATIOS
5.16%
GROSS MARGIN
-465.33%
OPERATING MARGIN
-1494.18%
NET MARGIN
842.93%
ROE
-365.10%
ROA
-29082.15%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Akanda Corp.
| Net Income | -32.3 M |
| Depreciation & Amortization | 4.28 M |
| Capital Expenditures | -1.5 K |
| Stock-Based Compensation | 0 |
| Change in Working Capital | 3.15 M |
| Others | 23.5 M |
| Free Cash Flow | -1.5 M |
Wall Street Analysts Price Targets
Akanda Corp.
AKAN has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Akanda Corp.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|
7. News
Akanda Corp. Announces Reverse Stock Split
London, United Kingdom--(Newsfile Corp. - November 12, 2024) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-2 reverse stock split of the Company's common shares effective November 14, 2024. The reverse stock split was previously approved by the Company's shareholders on March 22, 2024 and Board of Directors on October 25, 2024 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market on November 14, 2024 under the existing ticker symbol "AKAN".
newsfilecorp.com
- 4 days ago
Akanda Corp. Announces Closing of Underwritten Public Offering
London, United Kingdom--(Newsfile Corp. - October 4, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, entered into an underwriting agreement (the "Underwriting Agreement") with Univest Securities, LLC ("Univest") as the underwriter in connection with the issuance and sale by the Company in an underwritten public offering (the "Offering") of 258,940 of the Company's Common Shares, no par value per share (the "Common Shares" and, such number of Common Shares issued and sold in the Offering, the "Offered Shares"), at a purchase price of $1.00 per Offered Share, and 1,241,060 pre-funded warrants to purchase 1,241,060 Common Shares at a purchase price of each pre-funded warrant equal to the price at which one Common Share is sold in the Offering, minus $0.0001, and the exercise price of each pre-funded warrant is $0.0001 per share (the "Pre-Funded Warrants" and, such number of Pre-Funded Warrants issued and sold in the Offering, the "Offered Pre-Funded Warrants"), pursuant to the Company's effective registration statement on Form F-1 (File No. 333-281945) and a related preliminary prospectus, together with the related final prospectus dated as of October 2, 2024 (such registration statement, preliminary prospectus and the final prospectus, collectively, the "Registration Statement"), filed with the Securities and Exchange Commission.
newsfilecorp.com
- 1 month ago
Akanda Corp. Announces Pricing of Underwritten Public Offering
London, United Kingdom--(Newsfile Corp. - October 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a firm commitment underwriting agreement with Univest Securities, LLC, as underwriter, whereby Univest has agreed to purchase 1,500,000 common shares (or pre-funded warrants in lieu thereof) at a public offering price of $1.00 per share or $0.9999 per pre-funded warrant in an underwritten public offering. The gross proceeds to Akanda are estimated to be approximately $1,500,000 before deducting the underwriter fees and other offering expenses payable by the Company.
newsfilecorp.com
- 1 month ago
Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement
London, United Kingdom--(Newsfile Corp. - September 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), a global cannabis company, is excited to announce that it has obtained a license for hemp cultivation in Canada. This license is directly tied to Akanda's previously announced agreement with 1107385 B.C.
newsfilecorp.com
- 2 months ago
Why Is Akanda (AKAN) Stock Up 34% Today?
Akanda (NASDAQ: AKAN ) stock is on the rise Friday alongside heavy pre-market trading of the cannabis company's shares this morning. This has more than 6.8 million shares of AKAN stock changing hands as of this writing.
investorplace.com
- 3 months ago
Akanda Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
London, United Kingdom--(Newsfile Corp. - June 14, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announced that it has received a letter (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") dated June 7, 2024, informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). As previously announced, Akanda received a notification letter from Nasdaq dated July 3, 2023 indicating that its common shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of Nasdaq.
newsfilecorp.com
- 5 months ago
Akanda Corporation Announces Completion of F-3 Shelf Registration Statement
London, United Kingdom--(Newsfile Corp. - June 14, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has successfully completed sales of its securities under its existing Form F-3 shelf registration. The shelf registration statement had a $5 million capacity and allowed the Company to raise cash by selling stock and warrants into the open market.
newsfilecorp.com
- 5 months ago
Akanda Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
London, United Kingdom--(Newsfile Corp. - June 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has received a letter (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") dated June 7, 2024, informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). As previously announced, Akanda received a notification letter from Nasdaq dated July 3, 2023 indicating that its common shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of Nasdaq.
newsfilecorp.com
- 5 months ago
Penny Stocks That Pack a Punch: 3 Names to Ride for 10X Gains
One of the many advantages of penny stocks is that you can easily create a customized portfolio. diversified across various sectors, geographies, and business types, allowing for the creation of a tailored portfolio that aligns closely with individual investment goals.
investorplace.com
- 5 months ago
Why Is Akanda (AKAN) Stock Up 133% Today?
Akanda (NASDAQ: AKAN ) stock is rocketing higher on Friday alongside heavy pre-market trading of the cannabis company's shares. This has more than 6.3 million shares of AKAN stock changing hands as of this writing.
investorplace.com
- 5 months ago
Akanda Announces Stock Consolidation
London, United Kingdom--(Newsfile Corp. - May 21, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, reported that it expects to implement a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on The Nasdaq Capital Market under the symbol "AKAN".
newsfilecorp.com
- 5 months ago
Akanda Announces Closing of Subsequent Registered Direct Offering
London, United Kingdom--(Newsfile Corp. - May 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced second registered direct offering for the sale and issuance of 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded warrants to purchase 12,057,600 common shares at $0.103 per share, priced at the Minimum Price under the Nasdaq rules. The pre-funded warrants are immediately exercisable for $0.0001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.
newsfilecorp.com
- 5 months ago
8. Profile Summary
Akanda Corp. AKAN
COUNTRY
GB
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 2 M
Dividend Yield
0.00%
Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Contact
1a, 1b Learoyd Road, New Romney, TN28 8XU
https://www.akandacorp.com
IPO Date
March 15, 2022
Employees
46
Officers
Ms. Katharyn Field
Interim Chief Executive Officer & Executive Director
Dr. Gurcharn Deol B.A., M.A., Ph.D.
Chief Financial Officer